PHMB.US Pharmacom Biovet Inc

Healthcare Health Care Providers & Services USA Stocks
- USD
Market cap
-
P/E
-
P/B
-
ROE
-308.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2003.

Is PHMB.US undervalued?

Graham number

The Graham number of Pharmacom Biovet Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Pharmacom Biovet Inc fundamental analysis

No fundamental analysis for Pharmacom Biovet Inc yet.

Pharmacom Biovet Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Pharmacom Biovet Inc

PharmaCom BioVet, Inc. focuses on operating a network of companion animal cancer treatment centers in the United States. The company focuses on developing bone marrow transplantation and other cancer treatment procedures to benefit companion animals that are diagnosed with lymphoma, other different types of cancers, and other diseases that are incurable. It has licensed a series of proprietary devices and compounds that would reduce suffering in animals with cancer. The comp…

Full company profile